Acute Myeloid Leukemia Refractory research hub

A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

This study is testing a new drug, APL-4098, alone and with other medicines, for adults with certain types of blood cancers like Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS). Doctors want to see if it's safe, how well it's tolerated, and if it helps.